GSKMEX:GSKN 73 Market Cap is MXN1,805,212 Mil as of Jun. 24, 2026. GuruFocus rates MEX:GSKN with a GF Score™ of 73/100 and a GF Value™ of MXN818.82 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,023 Drug Manufacturers companies, GSK ranks better than 98.73% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). GSK's share price for the quarter that ended in Mar. 2026 was MXN1040. GSK's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 2,010 Mil. Therefore, GSK's market cap for the quarter that ended in Mar. 2026 was MXN2,090,539 Mil.
GSK's quarterly market cap
increased
from Sep. 2025 (MXN1,509,877 Mil) to Dec. 2025 (MXN1,733,422 Mil) and
increased
from Dec. 2025 (MXN1,733,422 Mil) to Mar. 2026 (MXN2,090,539 Mil).
GSK's annual market cap
increased
from Dec. 2023 (MXN1,271,151 Mil) to Dec. 2024 (MXN1,326,266 Mil) and
increased
from Dec. 2024 (MXN1,326,266 Mil) to Dec. 2025 (MXN1,733,422 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. GSK's Enterprise Value for Today is MXN2,156,867 Mil.
GSK (MEX:GSKN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
GSK Market Cap Related Terms
GSK Market Cap Historical Data
* Premium members only.
The historical data trend for GSK's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, GSK's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GSK Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GSK's Market Cap distribution charts can be found below:
* The bar in red indicates where GSK's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
GSK's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GSK (MEX:GSKN) has a Market Cap of MXN1,805,212 Mil as of Jun. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on GSK and its competitors. According to the industry distribution chart, GSK ranks #13 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 1.3%.
Is GSK's Market Cap too high?
GSK's current Market Cap is MXN1,805,212 Mil. Based on the distribution chart, GSK ranks #13 out of 1023 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, GSK has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GSK's Market Cap compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GSK ranks #13 out of 1023 companies for Market Cap. This places GSK in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 207.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 207.38, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on GSK and its competitors. For the Drug Manufacturers industry, the median Market Cap is 207.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GSK's current Market Cap is MXN1,805,212 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (MEX:GSKN) is currently considered Fairly Valued. The stock's GF Value™ is MXN818.82, compared to a current price of MXN901.11 — trading 10% above its estimated fair value. The current Market Cap is MXN1,805,212 Mil. GSK's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For GSK (MEX:GSKN), the current Market Cap is MXN1,805,212 Mil as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GSK (MEX:GSKN) Overvalued in 2026?
Based on GuruFocus' analysis, GSK stock appears to be overvalued.
The current stock price of MXN901.11 is trading 10% above its estimated GF Value™ of MXN818.82.
GuruFocus considers GSK to be Fairly Valued.
Key valuation signals for MEX:GSKN:
Market Cap: MXN1,805,212 Mil
GF Value™: MXN818.82 vs. price of MXN901.11 (10% above fair value)
No single metric tells the full story. See the MEX:GSKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
73GF Score
Get the complete analysis for MEX:GSKN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GSKN has been successfully added to your 
